Healthcare and Medical
Healthcare and Medical Company Financials
healthcare and medical | company financials
| Market | Report Title | Report Type | Country | Published | Cost |
|
FUKUDA DENSHI | Company Financials | Japan | 13/11/09 | £5.00 |
| The Company's principal activity is to produce and sell a range of medical equipment in Japan. The Company primarily offers cardiovascular and respiratory systems. Its cardiology products include | |||||
|
CUTERA | Company Financials | US | 13/11/09 | £5.00 |
| The Company is a global medical device company specializing in the design, development, manufacture, marketing and servicing of laser and other light-based aesthetics systems for practitioners | |||||
|
GENTIVA HEALTH SERVICES | Company Financials | US | 13/11/09 | £5.00 |
| The Company provides home health services throughout the United States. The Company operates in two business segments: Home Health, and prior to September 25, 2008, CareCentrix. | |||||
|
JAPAN MEDICAL DYNAMIC MARKETIN | Company Financials | Japan | 13/11/09 | £5.00 |
| The Company's principal activities are to import and wholesale medical appliances including bone joining materials, artificial joints, apparatus for spinal fusion, apparatus for high frequency used | |||||
|
PC GROUP | Company Financials | US | 13/11/09 | £5.00 |
| The Company designs, manufactures and distributes high-quality medical products and services targeting the long-term care, orthopedic, orthotic and prosthetic markets. | |||||
|
ARRHYTHMIA RESEARCH TECHNOLOGY | Company Financials | US | 13/11/09 | £5.00 |
| The Company licenses medical software that acquires data and analyzes electrical impulses of the heart to detect and aid in the treatment of potentially lethal arrhythmias. | |||||
|
INTERCELL | Company Financials | Austria | 13/11/09 | £5.00 |
| Intercell AG is a growing biotechnology company which focuses on the design and development of novel vaccines for the prevention and treatment of infectious diseases with substantial unmet medical | |||||
|
ILEX MEDICAL | Company Financials | Israel | 13/11/09 | £5.00 |
| The Company is an Israel-based company engaged directly and through its subsidiaries in the medical sector. | |||||
|
ODYSSEY HEALTHCARE | Company Financials | US | 13/11/09 | £5.00 |
| The Company is a provider of hospice care in the United States in terms of both patient census and number of Medicare-certified hospice programs. | |||||
|
ARRAY BIOPHARMA | Company Financials | US | 13/11/09 | £5.00 |
| The Company is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat debilitating and life-threatening diseases. | |||||
|
OCULUS INNOVATIVE SCIENCES | Company Financials | US | 13/11/09 | £5.00 |
| The Company a biopharmaceutical company, together with its subsidiaries, develops, manufactures, and markets products based on Microcyn platform technology that intends to help prevent and treat | |||||
|
HAW PAR CORPORATION | Company Financials | Singapore | 13/11/09 | £5.00 |
| The Group's core business is in healthcare and leisure products. These products promote healthy lifestyles through health products, dietary supplements, pharmaceuticals, and location-based | |||||
|
MEDICLIN | Company Financials | Germany | 13/11/09 | £5.00 |
| The Group operates in the health-care sector and covers the entire treatment chain of medical care. | |||||
|
AMREYAH PHARMACEUTICALS CO | Company Financials | Egypt | 13/11/09 | £5.00 |
| The Company is mainly engaged in the manufacture and distribution of pharmaceutical and veterinary products, specialized food and medical necessities, cosmetics and pesticides, as well as medical | |||||
|
NUVASIVE | Company Financials | US | 13/11/09 | £5.00 |
| The Company is a medical device company focused on the design, development and marketing of products for the surgical treatment of spine disorders. | |||||
|
ORTHOVITA | Company Financials | US | 13/11/09 | £5.00 |
| The company is a spine and orthopedic biosurgery company with proprietary biomaterials and biologic technologies for the development and commercialization of synthetic, biologically active, tissue | |||||
|
MUSTIKA RATU | Company Financials | Indonesia | 13/11/09 | £5.00 |
| The Company is engaged in the manufacturing, trading and distribution of herbal and traditional cosmetics, health drinks, and other related activities. | |||||
|
ORASURE TECHNOLOGIES | Company Financials | US | 13/11/09 | £5.00 |
| The Company develops, manufactures and markets oral fluid diagnostic products and specimen collection devices using its proprietary oral fluid technologies, as well as other diagnostic products, | |||||
|
YOUNG INNOVATIONS | Company Financials | US | 13/11/09 | £5.00 |
| The Company develops, manufactures and markets supplies and equipment used by dentists, dental hygienists, dental assistants and consumers. | |||||
|
ACCURAY | Company Financials | US | 13/11/09 | £5.00 |
| The Company designs, develops, and sells the CyberKnife system, an image-guided robotic radiosurgery system used for the treatment of solid tumors. | |||||
|
ROCKWELL MEDICAL TECHNOLOGIES | Company Financials | US | 13/11/09 | £5.00 |
| The Company manufactures, sells and distributes hemodialysis concentrates and other ancillary medical products and supplies used in the treatment of patients with End Stage Renal Disease, or ?ESRD?. | |||||
|
SYNERGY HEALTH | Company Financials | UK | 13/11/09 | £5.00 |
| The principal activities of the Group are the provision of outsourced healthcare and contract sterilisation services. | |||||
|
RES CARE | Company Financials | US | 13/11/09 | £5.00 |
| The Company is a provider of residential, training, educational and support services to populations with special needs, including persons with developmental and other disabilities and at-risk and | |||||
|
EXACTECH | Company Financials | US | 13/11/09 | £5.00 |
| The Company develops, manufactures, markets, distributes and sells orthopaedic implant devices, related surgical instrumentation and biologic services to hospitals and physicians in the United | |||||
|
CAPITAL SENIOR LIVING | Company Financials | US | 13/11/09 | £5.00 |
| The Company engages in the ownership, operation, development, and management of senior living communities in the United States | |||||
